News
Drugmaker Eli Lilly (NYSE: LLY) hasn't been exempt from the recent market pullback, but its stock shot higher following the ...
Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...
Physicians are turning to other options, including older, cheaper medications, as compounding GLP-1s comes to an end.
Two common GLP-1 medications that are approved by the Food and Drug Administration (FDA) specifically for weight loss are ...
The Trump Administration is dropping a Biden-era proposal that aimed to expand medicare and medicaid coverage to include costly weight-loss drugs.
“There are GLP-1 receptors all over the body ... Ozempic and Mounjaro are approved by the U.S. Food and Drug Administration to treat Type 2 diabetes, while Wegovy and Zepbound are approved ...
Hydreight Technologies Expands GLP-1 Telehealth Suite with Launch of Liraglutide on VSDHOne Platform
This mix of injectable, sublingual, and buccal options positions Hydreight as a category leader in GLP-1 administration versatility. It allows medical professionals to provide customized ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback